AI in Biopharma

Discover how artificial intelligence in healthcare is enhancing pharmacovigilance and how the future of pharmacovigilance will be impacted by AI in healthcare.

Artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical development. This report is the third in our series on the impact of AI on the biopharma value chain.

A report on how AI can improve biopharma launches and sales, helping to get the right drugs to the right patients and gain a competitive edge.

​Drug discovery is long, expensive and often unsuccessful. AI-enabled solutions are transforming the process and shifting health care towards a future where medicine is personalised, predictive, preventative and precise.

This report explores the potential for AI technologies to improve the safety, productivity and costs of the biopharma supply chain and manufacturing processes.

The pace and scale of medical and scientific innovation is transforming the biopharma industry. The need for better patient engagement and experience is spurring new business models. AI is rising across biopharma.